The SR-B1 Receptor as a Potential Target for Treating GlioblastomaEthan Berney, Andras G. Lacko(University of North Texas)Journal of OncologyJune 3, 201910.1155/2019/1805841Cited by 29SaveCiteExport RISWatch citationsRelated PapersMannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness|Pharmaceutics|2023|14Mannose-functionalization of reconstituted high-density lipoprotein nanoparticles improves payload delivery and enhances M2-to-M1 phenotype reprogramming of RAW 264.7 macrophages polarized by B16-F10 melanoma cells|Frontiers in Drug Delivery|2023|4